期刊文献+

定点诱变法构建p53基因多态质粒

Construction of p53 polymorphic plasmid by site-directed mutagenesis
下载PDF
导出
摘要 目的:为了研究p53codon72多态的功能,采用定点诱变法构建人p53基因的多态质粒。方法:设计带有突变碱基的引物,通过PCR扩增引入突变碱基,再将突变后的p53序列插入载体中,经测序确定所扩增的DNA序列,并用体外转录翻译系统制备p53蛋白和i ASPP蛋白,免疫沉淀法检测蛋白相互作用。结果:通过PCR获得的含突变碱基的p53序列经连接后插入真核表达载体pReceiver-M01中,构建了p53多态位点为72Arg的表达质粒pReceiver-M01-p53(Arg72)。测序证明序列正确,表达的p53蛋白能与i ASPP相互作用,具有生物学功能。结论:成功构建了p53多态(72Arg)真核表达载体,为进一步深入研究p53多态的生物学功能奠定了基础。 OBJECTIVE:To investigate the function of p53 polymorphic variants,we constructed the p53 codon 72 polymorphic plasmid.METHODS:Primers carrying the appropriate mutation were employed in a two-step PCR amplification.The mutated PCR products were subsequently cloned into pReceiver-M01 expression vector.The p53 protein translated in vitro was used to interact with iASPP to certify its biological activity.RESULTS:The sequence of the recombinant eukaryotic expression vector containing CCC to CGC mutation was proved by DNA sequencing.This p53 polymorphic variant could interact with iASPP,implying its biological activitical.CONCLUSION:The recombinant p53 eukaryotic expression vector containing codon 72 polymorphism was constructed successfully,laying a foundation for further studies on the function of p53.
出处 《癌变.畸变.突变》 CAS CSCD 2010年第3期182-185,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 国家自然科学基金资助项目(30971140) 重庆市科委自然科学基金资助项目(CSTC 2008BA5003)
关键词 p53多态 定点诱变 重叠延伸PCR p53 polymorphism site-directed mutagenesis overlap extension PCR
  • 相关文献

参考文献13

  • 1Dai S,Mao C,Jiang L,et al.P53 polymorphism and lung cancer susceptibility:a pooled analysis of 32 case-control studies[J].Hum Genet,2009,125(5/6):633-638.
  • 2Cao Z,Song JH,Park YK,et al.The p53 codon 72 polymorphism and susceptibility to coloreetal cancer in Korean patients[J].Neoplasma,2009,56(2):114-118.
  • 3Hoffmann M,Scheunemann K,Fazel A,et al.Human papiliomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma[J].Oneol Rep,2009,21(3):809-814.
  • 4Almeida PS,Manoel WJ,Reis AA,et al.TP53 codon 72 polymorphism in adult soft tissue sarcornas[J].Genet Mol Res,2008,7(4):1344-1352.
  • 5Ellis NA,Huo D,Yildiz O,et al.MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility[J].Blood,2008,112(3):741-749.
  • 6Storey A,Thomas M,Kalita S,et al.Role of a p53 polymorphism in the development of human Papillomavims-associated cancer[J].Nature,1998,393(6682):229-234.
  • 7Minaguchi T,Kanamori Y,Matsushima M,et al.No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection[J].Cancer Res,1998,58(20):4585-4586.
  • 8Whibley C,Pharoah PD,Hollstein M.p53 polymorphisms:cancer implications[J].Nat Rev Cancer,2009,9(2):95-107.
  • 9Liu ZJ,Gao X,Cai Y,et al.Construction of a Full-length iASPP expression plasmid pcDNA3.1(+)/iASPP and its biologic8l activity[J].Plasmid,2009,62(1):10-15.
  • 10蔡云,高兴,辛海明,陈杰,扬新,刘泽军.人完整p53凋亡刺激蛋白家族抑制成员多克隆抗体的制备及鉴定[J].医学研究生学报,2009,22(3):240-243. 被引量:5

二级参考文献11

  • 1陈杰,辛海明,蔡云,侯露,王刚,刘利,卢欣,钟山,刘泽军.人iASPP全长CDS的分段扩增、克隆及鉴定[J].第三军医大学学报,2007,29(11):996-998. 被引量:4
  • 2Samuels-Lev Y, OConnor DJ, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53[J]. Mol Cell 2001,8 (4) : 781-794.
  • 3Liu Z J, Lu X, Zhong S. ASPP-apoptotic specific regulator of p53 [J]. Biochim Biophys Acta, 2005, 1756 ( 1 ) : 77-80.
  • 4Bergamaschi D, Samuels Y, O' Neil N J, et al. iASPP oncoprorein is a key inhibitor of p53 conserved from worm to human[ J]. Nat Genet, 2003, 33(2) : 162-167.
  • 5Liu ZJ, Zhang Y, Zhang XB, et al. Abnormal mRNA expression of ASPP members in leukemia cell lines[ J]. Leukemia, 2004, 18(4) : 880.
  • 6Zhang X, Wang M, Zhou C, et al. The expression of iASPP in acute leukemias[J]. Leuk Res, 2005, 29(2) : 179-183.
  • 7Liu ZJ, Xin HM, Chen J, et al. A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53[J]. Leukemia Res, 2007, 31(8): 1161-1169.
  • 8Slee EA, Gillotin S, Bergamaschi D, et al. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization [ J ]. Oncogene, 2004, 23 (56) : 9007-9016.
  • 9Zhang X, Diao S, Rao Q, et al. Identification of a novel isoform of iASPP and its interaction with p53 [ J]. J Mol Biol, 2007, 368 (4) : 1162-1171.
  • 10虞伟,张燕,李晓军,武建国.抗-B淋巴细胞刺激因子自身抗体酶联免疫吸附法的建立和临床初步应用[J].医学研究生学报,2007,20(10):1014-1017. 被引量:4

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部